Pelvic fracture clot risk revealed in new study
NCT ID NCT07165587
First seen Oct 31, 2025 · Last updated May 14, 2026 · Updated 28 times
Summary
This study tracked 81 adults with pelvic or hip socket fractures to see how many developed dangerous blood clots despite receiving standard clot-preventing medication. All participants got twice-daily enoxaparin shots and were screened with ultrasound. The goal was to measure clot rates and link them to fracture type and treatment, helping doctors better prevent complications.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VENOUS THROMBOEMBOLISM are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Department of Trauma and Reconstructive Surgery
Tübingen, Baden-Wurttemberg, 72076, Germany
Conditions
Explore the condition pages connected to this study.